PL3179982T3 - Sposób zwiększenia biodostępności i/lub przedłużenia działania oftalmicznego leku - Google Patents
Sposób zwiększenia biodostępności i/lub przedłużenia działania oftalmicznego lekuInfo
- Publication number
- PL3179982T3 PL3179982T3 PL15827671.7T PL15827671T PL3179982T3 PL 3179982 T3 PL3179982 T3 PL 3179982T3 PL 15827671 T PL15827671 T PL 15827671T PL 3179982 T3 PL3179982 T3 PL 3179982T3
- Authority
- PL
- Poland
- Prior art keywords
- prolonging
- bioavailability
- drug
- increasing
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
- B01J39/16—Organic material
- B01J39/18—Macromolecular compounds
- B01J39/20—Macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2437MU2014 | 2014-07-28 | ||
| IN2206MU2015 | 2015-06-09 | ||
| PCT/IN2015/050076 WO2016016908A1 (en) | 2014-07-28 | 2015-07-24 | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3179982T3 true PL3179982T3 (pl) | 2023-09-25 |
Family
ID=55216857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15827671.7T PL3179982T3 (pl) | 2014-07-28 | 2015-07-24 | Sposób zwiększenia biodostępności i/lub przedłużenia działania oftalmicznego leku |
Country Status (6)
| Country | Link |
|---|---|
| US (5) | US10172852B2 (pl) |
| EP (2) | EP3179982B1 (pl) |
| JP (1) | JP6567648B2 (pl) |
| ES (1) | ES2951202T3 (pl) |
| PL (1) | PL3179982T3 (pl) |
| WO (1) | WO2016016908A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3179982B1 (en) | 2014-07-28 | 2023-07-19 | Sun Pharma Advanced Research Company Ltd | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug |
| EP3470059B1 (en) | 2015-01-26 | 2020-04-01 | Bausch & Lomb Incorporated | Ophthalmic suspension composition |
| EP3328361B1 (en) * | 2015-07-27 | 2021-09-15 | Sun Pharma Advanced Research Company Ltd | Drug loaded nanoresin particles |
| US10020844B2 (en) | 2016-12-06 | 2018-07-10 | T&T Intellectual Property I, L.P. | Method and apparatus for broadcast communication via guided waves |
| US11241443B2 (en) | 2017-04-07 | 2022-02-08 | Sun Pharma Advanced Research Company Ltd. | Ophthalmic solution of bimatoprost |
| JP7170436B2 (ja) * | 2017-06-28 | 2022-11-14 | 千寿製薬株式会社 | 水溶性高分子を含む点眼剤 |
| JP6621955B2 (ja) * | 2018-03-30 | 2019-12-18 | 千寿製薬株式会社 | 水性液剤 |
| JP6653037B2 (ja) * | 2018-03-30 | 2020-02-26 | 千寿製薬株式会社 | 水性液剤 |
| AU2019315509B2 (en) | 2018-07-31 | 2025-06-26 | Microbion Corporation | Bismuth-thiol compositions and methods of use |
| AU2019312592B2 (en) | 2018-07-31 | 2025-06-26 | Microbion Corporation | Bismuth-thiol compositions and methods for treating wounds |
| JP2020033290A (ja) * | 2018-08-29 | 2020-03-05 | 興和株式会社 | 水性組成物 |
| JP6994061B2 (ja) * | 2019-02-15 | 2022-01-14 | ノバルティス アーゲー | 4-(7-ヒドロキシ-2-イソプロピル-4-オキソ-4h-キナゾリン-3-イル)-ベンゾニトリルの製剤 |
| US11564909B2 (en) * | 2020-11-30 | 2023-01-31 | Romeg Therapeutics Llc | Methods and compositions for oral pilocarpine liquid |
| WO2022153208A1 (en) * | 2021-01-13 | 2022-07-21 | Sun Pharma Advanced Research Company Limited | Method of reducing elevated intraocular pressure |
| US20240041869A1 (en) * | 2022-08-04 | 2024-02-08 | Bausch + Lomb Ireland Limited | Ophthalmic composition comprising an anti-allergen and a redness reduction agent |
| CA3264067A1 (en) * | 2022-08-04 | 2024-02-08 | Bausch + Lomb Ireland Limited | OPHTHALMIC COMPOSITION COMPRISING PILOCARPINE AND A REDNESS-REDUCING AGENT |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0725698B2 (ja) * | 1984-10-31 | 1995-03-22 | アルコン ラボラトリーズ インコーポレイテッド | 持続的放出性を有し快適に適用できる緑内障治療用の処方物 |
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| DE3722837A1 (de) * | 1987-07-10 | 1989-01-19 | Ruetgerswerke Ag | Ophthalmisches depotpraeparat |
| US5275820A (en) | 1990-12-27 | 1994-01-04 | Allergan, Inc. | Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles |
| US5296228A (en) | 1992-03-13 | 1994-03-22 | Allergan, Inc. | Compositions for controlled delivery of pharmaceutical compounds |
| EP0995435B1 (en) | 1997-05-14 | 2007-04-25 | Senju Pharmaceutical Co., Ltd. | Aqueous suspension preparations with excellent redispersibility |
| BR9913955A (pt) * | 1998-09-25 | 2001-06-12 | Alcon Lab Inc | Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular |
| US6258350B1 (en) * | 1999-01-20 | 2001-07-10 | Alcon Manufacturing, Ltd. | Sustained release ophthalmic formulation |
| AU4338700A (en) | 1999-05-12 | 2000-12-05 | Alcon Laboratories, Inc. | Use of polymeric adsorbents in pharmaceutical dosage forms |
| US7001615B1 (en) * | 2001-12-07 | 2006-02-21 | Alcon, Inc. | Sustained release ophthalmic, otic and nasal suspension |
| KR100990810B1 (ko) * | 2001-12-21 | 2010-10-29 | 알콘, 인코퍼레이티드 | 안과용 약물 및 이과용 약물을 위한 담체로서 합성 무기 나노입자의 용도 |
| BRPI0506983A (pt) * | 2004-01-20 | 2007-07-03 | Allergan Inc | composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico |
| US20050238695A1 (en) * | 2004-04-27 | 2005-10-27 | Atma Chaudhari | Lozenge for delivery of dextromethorphan |
| WO2008033924A2 (en) * | 2006-09-12 | 2008-03-20 | Board Of Regents Of The University Of Nebraska | Methods and compositions for targeted delivery of therapeutic agents |
| US9095506B2 (en) * | 2008-11-17 | 2015-08-04 | Allergan, Inc. | Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof |
| JP2013531044A (ja) | 2010-07-15 | 2013-08-01 | コリンシアン オフサルミック,インコーポレイティド | 点眼薬送達 |
| HK1208161A1 (en) * | 2012-05-03 | 2016-02-26 | Alcon Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
| EP3179982B1 (en) * | 2014-07-28 | 2023-07-19 | Sun Pharma Advanced Research Company Ltd | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug |
-
2015
- 2015-07-24 EP EP15827671.7A patent/EP3179982B1/en active Active
- 2015-07-24 ES ES15827671T patent/ES2951202T3/es active Active
- 2015-07-24 EP EP21199143.5A patent/EP3954362A1/en active Pending
- 2015-07-24 WO PCT/IN2015/050076 patent/WO2016016908A1/en not_active Ceased
- 2015-07-24 PL PL15827671.7T patent/PL3179982T3/pl unknown
- 2015-07-24 US US15/329,824 patent/US10172852B2/en active Active
- 2015-07-24 JP JP2017504698A patent/JP6567648B2/ja active Active
-
2018
- 2018-11-05 US US16/180,731 patent/US11058684B2/en active Active
-
2021
- 2021-06-17 US US17/304,309 patent/US11951106B2/en active Active
-
2022
- 2022-12-05 US US18/061,848 patent/US11931359B2/en active Active
-
2024
- 2024-02-14 US US18/441,901 patent/US12409175B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20210308130A1 (en) | 2021-10-07 |
| US20170239243A1 (en) | 2017-08-24 |
| US12409175B2 (en) | 2025-09-09 |
| EP3179982A1 (en) | 2017-06-21 |
| US20190070176A1 (en) | 2019-03-07 |
| JP6567648B2 (ja) | 2019-08-28 |
| US11931359B2 (en) | 2024-03-19 |
| US20240180902A1 (en) | 2024-06-06 |
| ES2951202T3 (es) | 2023-10-19 |
| EP3179982A4 (en) | 2017-12-27 |
| US11058684B2 (en) | 2021-07-13 |
| US10172852B2 (en) | 2019-01-08 |
| WO2016016908A1 (en) | 2016-02-04 |
| JP2017525686A (ja) | 2017-09-07 |
| US11951106B2 (en) | 2024-04-09 |
| US20230098352A1 (en) | 2023-03-30 |
| EP3954362A1 (en) | 2022-02-16 |
| EP3179982B1 (en) | 2023-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301322I2 (nl) | Repotrectinib en/of farmaceutisch aanvaardbare zouten daarvan | |
| PL3179982T3 (pl) | Sposób zwiększenia biodostępności i/lub przedłużenia działania oftalmicznego leku | |
| IL258931A (en) | Therapeutic compounds and methods | |
| IL248757A0 (en) | Controllable drug delivery system and method of use | |
| LT3212189T (lt) | Pakeisti chromanai ir naudojimo būdas | |
| EP4212536C0 (en) | BENZOXAZEPINE OXAZOLIDINONE COMPOUNDS AND METHODS OF USE | |
| HUE066468T2 (hu) | Idegnyugtató norketamin vegyületek és eljárások | |
| HUE046000T2 (hu) | Antiproferatív vegyületek és alkalmazásuk módszerei | |
| EP3205103C0 (en) | INTER AND INTRA UNIFICATION BLOCK COPY | |
| PT3548033T (pt) | Compostos e respectivos métodos de utilização | |
| EP3328333A4 (en) | SYSTEMS AND METHODS FOR CORNEAL IMPLANTS | |
| IL252172A0 (en) | Expandable drug delivery devices and method of use | |
| EP3970906C0 (en) | LASER ABLATION AND TREATMENT METHODS AND SYSTEMS | |
| HUE056287T2 (hu) | Pancreatitis kezelése | |
| EP3551036A4 (en) | STIMULUS AND EYE TRACKING SYSTEM | |
| PT3319612T (pt) | Oxisteróis e métodos de utilização dos mesmos | |
| EP3528737A4 (en) | MEDICAL SUPPORT | |
| IL253889A0 (en) | Detection of brain injury | |
| PL3457851T3 (pl) | Pochodne sobetiromu | |
| IL251167A0 (en) | Cytotoxic and anti-mitotic compounds, and methods of using the same | |
| BR112016025413A2 (pt) | método de fabricação de um inserto e inserto | |
| EP3639617A4 (en) | RAN ZONE ID CONFIGURATION | |
| FR3059559B1 (fr) | Descendeur autobloquant | |
| DK3137873T3 (da) | Viscometer and methods of use thereof | |
| EP3437644A4 (en) | MEDICINE |